🇺🇸 FDA
Pipeline program

VX-548

VX22-548-016

Phase 1 small_molecule completed

Quick answer

VX-548 for Pain is a Phase 1 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 7 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Pain
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials